Commentary · 27 Dec 2024
Short communicationPublished 31 Mar 2021
Acute kidney injury biomarkers in patients with ureteric stones after retrograde ureterolithotripsy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The conventional diagnosis of acute kidney injury is based on serum creatinine measurement, but this marker is not appropriate for early recognition. During last decade there were a lot of studies evaluating biomarkers of kidney injury after minimally invasive treatment of kidney stones. However, there is no published data about biomarkers level after treatment of ureteric stones. The aim of our study was to evaluate impact of different treatment methods on kidney parenchyma in patients with proximal ureteric stones. From 1st January to 31st October 2017 a total of 75 patients with unilateral large proximal ureteric stones were prospectively included in our study. They were randomized in three groups. In group 1 patient’s undergone to retrograde ureterolithotripsy, in group 2 ESWL was performed and in group 3 mini-percutaneous antegrade ureterolithotripsy was treatment method. In all groups some biomarkers level were measured, including KIM-1, NAG and cystatin C, preoperatively, 2 hours, 24 hours and 72 hours after procedure. Also, we evaluate stone-free rate (residual fragments 0.05). In all groups the mean KIM1, cystatin C and NAG level increased two hours after intervention. However, after 1 and 7 days in group 1 the level of all biomarkers was not significantly different compared to baseline level. In group 2 and 3 KIM-1 and NAG level increased after 1 and 7 days after intervention, but in group 2 elevation at 7 days was not significant. Complication rate in group 1, 2 and 3 was 16%, 8% and 28%. There was greater grade 2 complication (according to Clavien-Dindo). Our study showed that retrograde ureterolithotripsy is safe treatment method, which cause minimal kidney parenchyma injury, according to biomarkers level change. Percutaneous antegrade ureterolithotripsy is the most invasive but the most efficient method; however, first day after intervention biomarker elevation is comparable with ESWL, despite on its minimally-invasive nature. These data must be confirmed in large study with strict laboratory and clinical follow-up.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Clinical Nephrology and Therapeutics.
Short communication · 27 Dec 2024
Understanding diabetic nephropathy: pathophysiology, diagnosis, and treatment approaches.
Opinion · 27 Dec 2024
Exploring the complexities of mineral bone disorder (MBD): Pathophysiology, Diagnosis, and Therapeutic approaches.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical Nephrology and Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Shiranov K A”
- BylineArticles whose byline prints “Aboyan I A”
- BylineArticles whose byline prints “Pakus S M”
